Geron (GERN) has resumed trading after announcing it's discontinuing development of its GRN1005...

This news story has 2 comments:

Register or Login to rate comments »

shel113 Comments (7)
 
I sold of my Gern not long after they got out of the Stem Cell business. I mad a few dollars (but got hit when the stock price dived) but the reason for the purchase was buying into a leader in stem cell development. The company seemed to be going downhill and after holing on for some time it was time to hang it up. I am sorry that a company with what appeared to have cutting edge technology (which may yet be developed by Bio Time) has deteriorated to a point where it may cease to exist. I am considering Bio Time as an investment as I still believe that Geron's stem cell technology is very viable and has investment potential.
3 Dec 2012, 05:08 PM Reply Like

Wilbe Comments (2)
 
This company must be poorly led because this is the second or third thing they have terminated. I have lost quite a bit on this poorly run company.
3 Dec 2012, 08:21 PM Reply Like